Strata Critical Medical, Inc.
For the period ended Aug 4, 2026. Filed Aug 4, 2026.
View on SEC.govAbout this filing
A notice of a major event between regular reports, such as results, a deal or a change of executives. It is often the first formal record of the news.
Aug 4, 2026 · Filed Aug 4, 2026
SRTA$5.56+5.7%Stored close · as of Nov 6, 2026
Contents
EX-99.1 · SEQUENTIAL QUARTER COMPARISON
SEQUENTIAL QUARTER COMPARISON
| Three Months Ended June 30, · Three Months Ended March 31, | ||||
|---|---|---|---|---|
| 2026 · 2026 · % Change | ||||
| Clinical revenue: | ||||
| Transplant Clinical | $12,521 | $9,839 | 27.3% | |
| Acquisitions | 338 | — | NM(1) | |
| Transplant Clinical, excluding acquisitions | $12,183 | $9,839 | 23.8% | |
| Other Clinical | $11,745 | $9,946 | 18.1% | |
| Acquisitions | 1,149 | — | NM(1) | |
| Other Clinical, excluding acquisitions | $10,596 | $9,946 | 6.5% | |
| Total Clinical | $24,266 | $19,785 | 22.6% | |
| Acquisitions | 1,487 | — | NM(1) | |
| Total Clinical, excluding acquisitions | $22,779 | $19,785 | 15.1% | |
| Clinical gross profit /margin: | ||||
| Clinical gross profit | $6,327 | $4,952 | 27.8% | |
| Clinical gross margin | 26.1% | 25.0% | 110 | bps |
| Net (loss) income from continuing operations | $(10,516) | $2,402 | (537.8)% | |
(1) Not meaningful.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.